Additionally, polymorphisms in the IL-2, IL-4, IL-6 and IL-10 genes associated with clinical RHD, and the discriminative value of IL-4 (both gene polymorphism and phenotypic expression), to differentiate between latent and clinical RHD were reinforced [26]. This evidence concerns the gene IL6 and rheumatic heart disease.